Chemotherapy for Lung Cancer Guide
Chemotherapy for lung cancer is designed according to the symptoms, type of the cancerous stage, patient age, time of approach of the affected patient to the cancer specialist, etc. In general both the attending physician and the patient should be aware of baseline technical information on the kind of chemotherapy for lung cancer proposed.
Toxicity during chemotherapy for lung cancer
Chemotherapy may include anti-cancerous drugs often in combination like cisplatin, which is often given by intravenous route in patients with lung cancer. However, it is to be understood that the effects of chemotherapy for lung cancer depends more specifically on type of lung cancer and extent of it's spread. If metastasis is encountered extensively in organs like liver, kidney, bone, etc., or if it is a small cell lung cancer, then the chemotherapy for lung cancer may not be much successful. However, one has to alleviate the signs of pain in the patient by the lung cancer and hence, along with combination chemotherapy for lung cancer, supportive therapy is also required. Chemotherapy for lung cancer includes medicaments that are specifically well known and marketed after undergoing rigorous clinical trials in affected patients to cause anti tumor effects. During such therapy, the patient should analyze the symptoms he is experiencing and communicate to the thoracic specialist signs like pain factor in the region. It is to be understood that if the mediastinal lymph node is involved then the intensity of pain will be greater and is at times intolerable, thus warranting immediate medical intervention symptomatically. During chemotherapy both the affected patient and the attending physician have to exercise great cautions without leaving the targeted treatment unless it requires so. Monitoring during chemotherapy
Monitoring is required in patients receiving multiple drugs. This monitoring is essential because of the fact that there are certain medicaments that can affect severely the hepatic system or blood cells in body. There are recorded incidences of renal damage by drugs used under the pretext of chemotherapy for lung cancer. The experienced clinical oncologist will be carefully monitoring the patient for presence of any symptoms of affection in nervous system, also. These types of clinical precautions must be undertaken on a priority basis. The significance of this is because of the fact that though anti-cancerous effects are documented with chemotherapy for lung cancer, it is equally true that side effects may occur in such patients because of the unexpected and unwarranted signs and symptoms due to their effects on various organs and their metabolites present in serum of the patients undergoing chemotherapy for lung cancer.
Contact us Home
Copyright © 2003 My Lung Cancer Guide
|